Felicitex Therapeutics Inc. (FLCT)

Felicitex Therapeutics was planning to go public, but the IPO was withdrawn on Feb 21, 2025.

IPO Price

$6.25

Shares Offered

2,480,000

Deal Size

$15.50M

Felicitex Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Income	-1.81	-1.41	-1.14
Net Income	-1.76	-1.35	-0.72

Fiscal Year	Current	FY 2021	FY 2020
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	0.03	0.01	0.04
Total Debt	0.25	0.25	0.53
Net Cash (Debt)	-0.22	-0.24	-0.49
Net Cash Growth	-	-	-

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-1.15	-0.89	-0.98
Capital Expenditures	0	-	-0
Free Cash Flow	-1.15	-0.89	-0.98
Free Cash Flow Growth	-	-	-